New investors acquired Airway Medix shares
New investors acquired 11.6 million Airway Medix shares for about PLN 3.944 million, around EUR 900,000. CoOpera holds 12.41 percent and Kröner Medizintechnik 3.54 percent of the company after the transaction.
Warsaw, November 20, 2023: Airway Medix is finalizing agreements regarding the acquisition of issue shares within the authorized capital in the amount of PLN 3.944 million (EUR 900,000) by new investors: CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. New investors will invest up to EUR 2 million and will be operationally involved in the commercialization of products on the EU and US markets.
As a result of the agreements, 11.6 million shares were acquired, and CoOpera Finanzierungen Deutschland and Kröner Medizintechnik will become owners of 12.41 percent and 3.54 percent of the increased share capital.
Airway Medix focuses on innovative medical devices supporting the process of mechanical ventilation of patients, holding international patents. Partners, thanks to their experience in the industry, will support product development and commercialization processes.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Press releases are published as issued by Airway Medix S.A. Product statements follow the instructions for use.
